EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rational Method for Structural Simplification as Key Step in Hit Discovery: The Case of FGFR2 and IGF1R Dual Inhibitors

Endika Torres-Urtizberea iD, José I Borrell iD, Raimon Puig de la Bellacasa iD, Roger Estrada-Tejedor

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26094457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Endika Torres-Urtizberea und 3 weiteren Autor:innen. Beteiligte Einrichtung: Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 2, Receptor, IGF Type 1, Drug Discovery, Protein Kinase Inhibitors. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Spanish Government, Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the classic medicinal chemistry hit discovery procedure, large virtual libraries undergo different filtering and prediction steps until a small group of molecules is selected for their subsequent synthesis and biological testing. The starting molecular libraries can easily be composed of millions of molecules, hindering the selection of the most representative and promising compounds. Moreover, the resulting molecular systems tend to be overcomplex structures, hardly attainable, and often involve extrapolations of the prediction models used. We present a rational-based method to reduce the structural complexity of molecular candidates without compromising their biological activity, improving the attainability and efficiency of hit discovery. This approach has been successfully applied to identify potential tyrosine kinase dual inhibitors against Fibroblast Growth Factor Receptor 2 (FGFR2) and Insulin-Like Growth Factor 1 Receptor (IGF1R), a set of overexpressed proteins in different cancers, such as pancreatic ductal adenocarcinoma (PDAC).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Fibroblast Growth Factor, Type 2Receptor, IGF Type 1Drug DiscoveryProtein Kinase InhibitorsAntineoplastic AgentsHumansQuantitative Structure-Activity RelationshipCarcinoma, Pancreatic DuctalPancreatic Neoplasms

Stichwörter der Autor:innen

QSARhit discoverystructure complexity

Substanzen

Receptor, Fibroblast Growth Factor, Type 2Receptor, IGF Type 1Protein Kinase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain.

ORCID-Profile: Endika Torres-Urtizberea, José I Borrell, Raimon Puig de la Bellacasa

Förderung

  • Ministerio de Ciencia, Innovación y Universidades
  • Spanish Government, Ministerio de Ciencia e Innovación

Zitieren

APA

Torres-Urtizberea, E., Borrell, J. I., Puig de la Bellacasa, R., & Estrada-Tejedor, R. (2025). Rational Method for Structural Simplification as Key Step in Hit Discovery: The Case of FGFR2 and IGF1R Dual Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094457

Vancouver

Torres-Urtizberea E, Borrell JI, Puig de la Bellacasa R, Estrada-Tejedor R. Rational Method for Structural Simplification as Key Step in Hit Discovery: The Case of FGFR2 and IGF1R Dual Inhibitors. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094457

BibTeX
@article{TorresUrtizberea2025,
  author = {Torres-Urtizberea, Endika and Borrell, José I and Puig de la Bellacasa, Raimon and Estrada-Tejedor, Roger},
  title = {Rational Method for Structural Simplification as Key Step in Hit Discovery: The Case of FGFR2 and IGF1R Dual Inhibitors},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26094457}
}
Kostenlos starten →